Clinical Trials Directory

Trials / Unknown

UnknownNCT03977545

Actigraphy and Neonatal Abstinence Syndrome

Assessment of Actigraphy in the Management of Neonatal Opioid Abstinence Syndrome

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
1 Day
Healthy volunteers
Accepted

Summary

The aim of our study is to analyse the correlation between actigraphy and Lipsitz scoring system in neonatal opioid abstinence syndrome.

Detailed description

Neonatal opioid abstinence syndrome occurs after birth when opioids were used by the mother during pregnancy. Many scoring systems, like Lipsitz scoring system, are used to diagnose and manage neonatal abstinence syndrome but they are subjective. The majority of items in these scores are motor skills items. Actigraphy allows to measure objectively the newborn motricity. We will analyse the correlation between actigraphy and Lipsitz scoring system in four groups of newborns.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTActigraphyActigraphy will be realized twice a day during 30 minutes and Lipsitz scoring system will be realized at the same moment to analyze the correlation between Lipsitz scoring system and actigraphy in each arm.

Timeline

Start date
2019-01-23
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2019-06-06
Last updated
2021-05-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03977545. Inclusion in this directory is not an endorsement.